Document is current
Any future updates will be listed below
-
Authors
Wang, Zhenda
Mierxiati, Abudurexiti
Zhu, Wenkai
Li, Tian
Xu, Hua
Wan, Fangning
Ye, Dingwei
-
Funding
Funding for this research was provided by:
Grants from the National Key Research and Development Program of China (No.2019YFC1316005, No.2019YFC1316005)
National Natural Science Foundation of China (No.82473505, No.81802525 and No.81902568, No.82473505, No.81802525 and No.81902568)
Shanghai Science and Technology Committee (No.20ZR1413100, No.18511108000, No.20ZR1413100, No.18511108000)
Shanghai Sailing Program (No.19YF1409700, No.19YF1409700)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 6 April 2025
First Online: 3 May 2025
Competing interests
: The authors declare no competing interests.
: The procedures for tumor xenografts were carried out according to the approved protocol by The Institutional Animal Care and Use Committee at Fudan University. Each patient provided written informed consent prior to the obtaining of tumor tissue, and the procedure was executed in compliance with institutional and state laws governing the use of human tissues for experimental purposes.
: The study was carried out in strict accordance with the principles enshrined in the Declaration of Helsinki, and was approved by the Medical Ethics Committee of Cancer Hospital, Fudan University (SCCIRB). Written informed consent was acquired from all participants.
